# Effects of Pregnane X Receptor (PXR) Activation on Human Glucose, Lipid and Hormone Homeostasis

> **NCT01293422** · PHASE4 · COMPLETED · sponsor: **University of Oulu** · enrollment: 12 (actual)

## Conditions studied

- Glucose Metabolism

## Interventions

- **DRUG:** Rifampicin

## Key facts

- **NCT ID:** NCT01293422
- **Lead sponsor:** University of Oulu
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01293422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01293422, "Effects of Pregnane X Receptor (PXR) Activation on Human Glucose, Lipid and Hormone Homeostasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01293422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*